Catalyst Wire Dossier Catalyst Wire Dossier

CIML NK Cell Infusion

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CIML NK Cell Infusion, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation [Phase 1]

See pricing